Mostrando 1 - 20 resultados de 30 para a busca 'Sh. I. Musin', tempo de busca: 0.07s
Refinar Resultados
-
1
ORAL CANCER: LYMPHO DISSECTION AT CN0 AND CN+ por Sh. I. Musin
Publicado em 2017-01-01
Artigo -
2
PERIOPERATIVE ASSESSMENT OF CHEMILUMINESCENCE INDICATORS OF LYMPH NODES IN TONGUE CANCER por Sh. I. Musin, R. R. Farkhutdinov
Publicado em 2017-01-01
Artigo -
3
Predictors of Multiple Primary Malignancies: Literature Review por A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva
Publicado em 2023-10-01
Artigo -
4
Features of the Course of Radioinduced Breast Cancer. Clinical Observation por M. M. Zamilov, K. V. Menshikov, Sh. I. Musin, A. V. Sultanbaev, G. I. Zamilova, A. H. Nguyen
Publicado em 2023-10-01
Artigo -
5
-
6
Clinical case of the treatment of metastatic luminal breast cancer por A. F. Nasretdinov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, A. A. Izmailov, R. T. Ayupov
Publicado em 2021-12-01
Artigo -
7
-
8
Eribulin in Metastatic Breast Cancer: Actual Clinical Practice por A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, V. E. Askarov
Publicado em 2023-04-01
Artigo -
9
Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer por A. F. Nasretdinov, N. I. Sultanbaeva, Sh. I. Musin, A. V. Pushkarev, K. V. Menshikov, V. A. Pushkarev, A. V. Sultanbaev
Publicado em 2020-06-01
Artigo -
10
Neuroendocrine Tumours: a Literature Review por K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, I. R. Shaykhutdinov
Publicado em 2021-05-01
Artigo -
11
Combined Use of Cabozantinib and Nivolumab in Clinical Practice por V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, E. V. Popova, I. A. Menshikova
Publicado em 2024-04-01
Artigo -
12
-
13
Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency por R. T. Ayupov, A. A. Izmailov, K. V. Menshikov, A. V. Sultanbaev, A. F. Nasretdinov, R. R. Rakhimov, Sh. I. Musin, N. I. Sultanbaeva
Publicado em 2021-12-01
Artigo -
14
-
15
-
16
Atezolizumab and Bevacizumab in Therapy for Patients with Hepatocellular Carcinoma in Real Clinical Practice por G. A. Serebrennikov, К. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov, A. Sh. Rezyapova
Publicado em 2023-07-01
Artigo -
17
-
18
Efficacy of the 1<sup>st</sup> generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens por K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, D. O. Lipatov
Publicado em 2022-06-01
Artigo -
19
Surgical stage in sequential therapy of unresectable oral cancer T3-4bN0-3M0: evaluation of treatment results por Sh. I. Musin, A. V. Sultanbayev, K. V. Menshikov, F. F. Mufazalov, A. F. Nasretdinov, O. V. Goncharova, S. V. Osokin, M. M. Zamilov, K. E. Timin
Publicado em 2022-02-01
Artigo -
20
Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case por A. V. Sultanbaev, Sh. I. Musin, K. V. Menshikov, A. F. Nasretdinov, B. A. Ibragimov, A. G. Nigmatullin, R. T. Ayupov, A. A. Izmailov, N. I. Sultanbaeva
Publicado em 2020-12-01
Artigo